RNS Number : 9140S
Induction Healthcare Group PLC
22 March 2021
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Induction Zesty surpasses 200,000 registered patients in the UK
Market-leading portal empowers patients to take control of their appointments, correspondence and clinical records from the convenience of their smartphone
Induction Healthcare (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, announces that its market-leading patient portal, Induction Zesty, has surpassed 200,000 patient users in the UK.
In March 2020, registered users of Induction Zesty had more than doubled from 32,000 to 76,000 in one year. In the subsequent 12 months, Induction Zesty saw exponential growth to reach 202,000 users today. With more than 700 new patient registrations daily, this number will continue its climb unabated, especially as hospital activity returns to pre-pandemic levels.
The platform serves as a digital front door for hospitals, with an intuitive interface that gives patients easy and secure access to appointment bookings, clinical letters and copies of clinical records. Additionally, at participating hospitals, Induction Zesty supports access to Apple's Health Records on iPhone.
Induction Zesty is employed by several NHS Trusts across the UK, including The Royal Free London NHS Foundation Trust, a Global Digital Exemplar, and Milton Keynes University Hospital NHS Trust, with whom Induction has been working for three years. Data from Milton Keynes show that 97% of patients report that Induction Zesty provides easy registration, and 85% say they prefer having online control over their appointments.
For more information on Induction Zesty visit: https://inductionhealthcare.com/zesty
James Balmain, Joint-CEO of Induction Healthcare, said: "These numbers are proof that Induction Zesty is a favoured and reliable platform. Patients appreciate the ease, convenience and accessibility of the portal, and hospitals benefit from a reduction in both time and costs - with greater staff satisfaction - when they involve patients in the management of their own care."
ENQUIRIES
Induction Healthcarehttps://inductionhealthcare.com
Dr Hugo Stephenson, Joint Chief Executive Officer
Via Walbrook PR
James Balmain, Joint Chief Executive Officer
N+1 Singer (Nominated Adviser and Broker)
+44 (0)20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd
+44 (0)20 7933 8780 or induction@walbrookpr.com
Paul McManus / Alice Woodings
+44 (0)7980 541 893 / +44 (0)7407 804 654
About Induction Healthcare - https://inductionhealthcare.com
Induction Healthcare (AIM: INHC) is a leading virtual care platform driving digital transformation of healthcare systems worldwide. Induction solutions enhance the investments hospital systems have made and lay the foundation for their future. Our products can enable information share between busy doctors, alleviate operational burdens on hospitals or put patients in better control of their care, all while ensuring the highest standards of clinical safety and information security. We unchain staff and patients from the limitations of paper-based and desktop systems - and that creates massive time and cost efficiencies.
More than 200,000 hospital doctors across multiple territories, including the UK, Ireland, Australia and South Africa, as well as a rapidly growing number of more than 200,000 UK patients, choose Induction solutions.
Induction Switch is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting.
Induction Guidance provides medical organisations, including most hospital trusts within the NHS, with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. This increases knowledge of, and adherence to, guidance.
Induction Zesty is a market-leading digital platform for patients visiting hospitals. The platform allows patients to book and access their appointments, read their clinical letters, store a copy of their clinical record and provide data to their care teams remotely. It is not just a compelling patient experience, but also delivers significant cost benefits to hospitals.
Induction HealthStream is a proprietary data integration platform that reads and writes patient demographic, appointment and clinical record data between a growing number of hospital EHR systems and the Induction platforms. This connectivity between stakeholders and legacy IT systems adds substantial value to pre-existing health IT investment and allows large-scale adoption of Induction app-based services.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAJLMITMTJBBRB
